Apotex Announces $184 Million Investment to Grow U.S. Manufacturing Presence; Expansion Plan Comprises Company's Largest Investment in the United States

SourcePR Newswire
Date Published03/08/2017
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Apotex
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):150
Year reshoring announced:2017
Year reshoring implemented or to be implemented:2019
Domestically, the work will be done:In-house
Capital investment ($):184
Country(ies) from which reshored:Canada
City reshored to:Miramar
State(s) reshored to:FL
If relevant, work nearshored to:-
What domestic positive factors made reshoring more attractive?Proximity to customers/market, Proximity to Latin America
Find Reshoring Articles